易瑞生物：控股股东及其一致行动人拟合计减持不超3%公司股份

Core Viewpoint - The company, EasyRegen Biotech (300942), announced plans for its major shareholders to reduce their stake in the company by up to 12.15 million shares, representing 3% of the total share capital [1] Group 1 - The controlling shareholder, EasyRegen Investment, along with its concerted parties, EasyDaRui and EasyKaiRui, intends to execute the share reduction through centralized bidding or block trading [1]